EUDA Health EUDA
Medical - Care Facilities, Healthcare
$15.57
−12.03%
- Market cap
- $29.4M
- PE
- n/m
- not a meaningful number
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- n/m
- not a meaningful number
- EV/EBIT
- n/m
- not a meaningful number
- Revenue, 12 months
- n/m
- not a meaningful number
- Net margin
- n/m
- not a meaningful number
- Free cash flow yield
- n/m
- not a meaningful number
Charts
Financials
| Income statement | Q3 FY21 | Q4 FY21 | Q1 FY22 | Q2 FY22 | Q1 FY22 | Q3 FY22 | Q4 FY22 | Q2 FY22 | Q1 FY23 |
|---|---|---|---|---|---|---|---|---|---|
| n/a | n/a | n/a | n/a | $2.7M | n/a | n/a | n/a | $1.7M−36% | |
| Cost of revenue | n/a | n/a | n/a | n/a | $1.4M | n/a | n/a | n/a | $1.3M−7% |
| Gross profit | n/a | n/a | n/a | n/a | $1.3M | n/a | n/a | n/a | $403.6K−68% |
| R&D | n/a | n/a | n/a | n/a | $2.9K | n/a | n/a | n/a | n/a |
| SG&A | n/a | n/a | n/a | n/a | $1.2M | n/a | n/a | n/a | $2.4M+100% |
| −$6.7K | −$528 | −$45.6K | −$225.6K | $75.3K | −$481.6K | −$1.2M | −$298.3K | −$2M | |
| Pre-tax income | n/a | n/a | n/a | n/a | $230.8K | n/a | n/a | n/a | −$2.4M |
| n/a | n/a | n/a | n/a | $5.8K | n/a | n/a | n/a | $985−83% | |
| Net income | −$6.7K | −$528 | −$45.6K | −$224.9K | $222.6K | −$473K | −$1M | $201K | −$2.4M |
| n/a | n/a | −$0.40 | n/a | $0.40 | n/a | n/a | n/a | −$2.40 | |
| n/a | n/a | 93.8K | n/a | 462.7K | n/a | n/a | n/a | 1M+118% |
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Healthcare nearest EUDA Health's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| EUDAEUDA Health | $29.4M | n/m | n/a | n/m | n/m | n/m | |
| NEPHNephros | $35.2M | 20.3× | 28.3× | 1.7× | +24% | 8.4% | |
| ATNMActinium Pharmaceuticals | $45M | 4.0× | 3.3× | n/m | n/m | n/m | |
| APTAlpha Pro Tech | $56.3M | 13.5× | 14.8× | 0.9× | +6% | 6.8% | |
| SPROSpero Therapeutics | $60.6M | 9.5× | 9.5× | 1.3× | −3% | 15.7% | |
| LFVNLifevantage | $73.5M | 14.7× | 19.4× | 0.4× | −20% | 2.8% | |
| ICCCImmucell | $95.9M | 132× | 44.1× | 3.1× | +8% | 2.6% | |
| KEQUKewaunee Scientific | $96.7M | 12.1× | 13.6× | 0.3× | +5% | 3.0% | |
| PDEXPro DEX | $184.5M | 15.9× | 16.5× | 2.3× | +13% | 15.1% | |
| PLXProtalix BioTherapeutics | $206.3M | 11.1× | 33.6× | 2.6× | +30% | 23.5% | |
| NATRNatures Sunshine Products | $211.5M | 11.9× | 20.2× | 0.4× | +7% | 3.7% | |
| Peer median | $84.7M | 12.8× | 18.0× | 1.3× | +7% | 6.8% |
More on EUDA Health
Each number over time
Its groups
About
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
Valuation data, not investment advice. Prices as of .